Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.19 USD
Change Today +0.09 / 4.29%
Volume 25.6K
GNVC On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - genvec inc (GNVC)

NameBoard RelationshipsTitleAge
Douglas J. Swirsky CPA, CFA33 RelationshipsChief Executive Officer, President, Corporate Secretary and Director45
James Vincent Lambert No RelationshipsPrincipal Financial Officer, Principal Accounting Officer, Senior Director of Accounting & Finance, Treasurer and Corporate Controller50
Bryan T. Butman Ph.D.No RelationshipsSenior Vice President of Development61
Douglas E. Brough Ph.D.No RelationshipsChief Scientific Officer59

Board Members - genvec inc (GNVC)

NameBoard RelationshipsPrimary CompanyAge
Wayne T. Hockmeyer Ph.D.41 RelationshipsGenVec, Inc.69
Douglas J. Swirsky CPA, CFA33 RelationshipsGenVec, Inc.45
William N. Kelley M.D.17 RelationshipsGenVec, Inc.74
Marc R. Schneebaum 14 RelationshipsSynta Pharmaceuticals Corp.60
Stefan D. Loren Ph.D.42 RelationshipsWestwicke Partners, LLC50

Executive Committees* - genvec inc (GNVC)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeMarc R. Schneebaum 14 Relationships3 Executives
Compensation CommitteeWayne T. Hockmeyer Ph.D. 41 Relationships3 Executives
Nominating CommitteeWilliam N. Kelley M.D. 17 Relationships3 Executives
Corporate Governance CommitteeWilliam N. Kelley M.D. 17 Relationships3 Executives
View GNVC Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNVC:US $2.19 USD +0.09

GNVC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Argos Therapeutics Inc $7.74 USD -0.10
Eurocine Vaccines AB kr2.27 SEK -0.02
Genocea Biosciences Inc $10.99 USD +0.59
Transgene SA €4.96 EUR 0.00
Vical Inc $0.92 USD +0.0024
View Industry Companies
 

Industry Analysis

GNVC

Industry Average

Valuation GNVC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.0x
Price/Book 3.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENVEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.